Informe de Evaluación de Tecnología Sanitaria y metaanálisis: comparación entre las formas farmacéuticas de tacrolimus
Sanguine, Verónica; Chaves, Silvia; Balaciano, Giselle.
Rev. argent. salud publica
; 8(33): 35-40, Dic. 2017. tab
Artigo em Espanhol | LILACS | ID: biblio-883187
Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.
Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique.
Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
Novel gastroretentive sustained-release tablet of tacrolimus based on self-microemulsifying mixture: in vitro evaluation and in vivo bioavailability test.
A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers.
Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up.
Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents.
A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506).
Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study.